Comments
Loading...

Century Therapeutics

IPSCNASDAQ
Logo brought to you by Benzinga Data
$1.65
00.00%
At close: Sep 18, 4:00 PM EDT
$1.65
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$24.00
Lowest Price Target1
$5.00
Consensus Price Target1
$14.00

Century Therapeutics (NASDAQ:IPSC) Stock, Analyst Ratings, Price Targets, Forecasts

Century Therapeutics Inc has a consensus price target of $14 based on the ratings of 8 analysts. The high is $24 issued by Canaccord Genuity on March 15, 2024. The low is $5 issued by JP Morgan on August 28, 2023. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Piper Sandler, and HC Wainwright & Co. on August 15, 2024, June 17, 2024, and June 4, 2024, respectively. With an average price target of $10.67 between HC Wainwright & Co., Piper Sandler, and HC Wainwright & Co., there's an implied 546.46% upside for Century Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Apr
0
0
0
0
May
1
Jun
0
0
0
0
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Piper Sandler
Canaccord Genuity
JP Morgan
EF Hutton

1calculated from analyst ratings

Analyst Ratings for Century Therapeutics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Century Therapeutics (IPSC) stock?

A

The latest price target for Century Therapeutics (NASDAQ:IPSC) was reported by HC Wainwright & Co. on August 15, 2024. The analyst firm set a price target for $9.00 expecting IPSC to rise to within 12 months (a possible 445.45% upside). 8 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Century Therapeutics (IPSC)?

A

The latest analyst rating for Century Therapeutics (NASDAQ:IPSC) was provided by HC Wainwright & Co., and Century Therapeutics maintained their buy rating.

Q

When was the last upgrade for Century Therapeutics (IPSC)?

A

There is no last upgrade for Century Therapeutics

Q

When was the last downgrade for Century Therapeutics (IPSC)?

A

The last downgrade for Century Therapeutics Inc happened on August 28, 2023 when JP Morgan changed their price target from $28 to $5 for Century Therapeutics Inc.

Q

When is the next analyst rating going to be posted or updated for Century Therapeutics (IPSC)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Century Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Century Therapeutics was filed on August 15, 2024 so you should expect the next rating to be made available sometime around August 15, 2025.

Q

Is the Analyst Rating Century Therapeutics (IPSC) correct?

A

While ratings are subjective and will change, the latest Century Therapeutics (IPSC) rating was a maintained with a price target of $11.00 to $9.00. The current price Century Therapeutics (IPSC) is trading at is $1.65, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch